KE Pharma Spółka z Ograniczoną Odpowiedzialościąsp. z o.o.
Manufacture of homogenised food preparations and dietetic food
Overview
KE Pharma Spółka z Ograniczoną Odpowiedzialością provides contract manufacturing of dietary supplements in tablet, capsule, sachet, drop and syrup forms, as well as animal preparations. Its services include formulation, technological trials, documentation and notifications related to supplement registration. The company also produces foods for special medical purposes, dermocosmetics and medical devices, following GMP and HACCP standards.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2017-08-01. Active
03 1090 1030 0000 0001 3489 8630- 53 1090 1030 0000 0001 3419 0697
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
4 public aid cases recorded, with a total value of $31,526.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 12, 2022 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Banku Gospodarstwa Krajowego | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board – the President of the Management Board; in the case of a multi-member management board, the President of the Management Board independently, two members of the management board other than the President of the Management Board acting jointly, a member of the management board acting with the President of the Management Board or a commercial proxy, if a commercial proxy is appointed. The disposal by the company of a right or incurring an obligation up to PLN 200,000.00 does not require a resolution of the partners’ meeting, provided that the management board is obliged to obtain the consent of the partners’ meeting before incurring an obligation related to the performance of periodic services with a value exceeding PLN 5,000.00 per month.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 80 | $2,160.99 | 20% | |
| 80 | $2,160.99 | 20% | |
Michał Jan Koziorowski | 80 | $2,160.99 | 20% |
Łukasz Artur Trznadel (46) | 160 | $4,321.99 | 40% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nutri Partnersp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| Gotabsp. z o.o. | $1,433,720.57 | gotab.pl | ||
| Auralab360sp. z o.o. | $1,385,659.31 | auralab360.pl | ||
| Methodo Polskasp. z o.o. | $1,337,205.31 | methodopolska.com | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io | ||
| IOCsp. z o.o. | $878,940.46 | producentsuplementow.pl | ||
| Bonafarmsp. z o.o. | $860,062.52 | bonafarm.pl | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com | ||
| Nexon Pharmasp. z o.o. | $574,250.90 | nexonpharma.pl | ||
| Amberpharmsp. z o.o. | $300,044.02 | amberpharm.eu |
Change history
| Date | Event | |
|---|---|---|
| 2023-11-27 | Share capital change (30,000.00 PLN → 40,000.00 PLN) | |
| 2018-09-12 | Share capital change (20,000.00 PLN → 30,000.00 PLN) | |
| 2018-03-02 | Share capital change (10,000.00 PLN → 20,000.00 PLN) | |
| 2017-07-12 | Address change (Al. Tadeusza Rejtana 20, 35-310, Rzeszów → Ul. Wólczyńska 232, 01-919, Warszawa) | |
| 2016-07-12 | Entered in the register |
FAQ
Last updated: 2026-08-17